• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Fertil Steril . Assessment of SARS-CoV-2 in Human Semen-A Cohort Study

tetano

Editor, Senior Moderator
Fertil Steril


. 2020 May 29;S0015-0282(20)30519-7.
doi: 10.1016/j.fertnstert.2020.05.028. Online ahead of print.
Assessment of SARS-CoV-2 in Human Semen-A Cohort Study


Nora Holtmann[SUP] 1 [/SUP], Philippos Edimiris[SUP] 1 [/SUP], Marcel Andree[SUP] 2 [/SUP], Cornelius Doehmen[SUP] 1 [/SUP], Dunja Baston-Buest[SUP] 3 [/SUP], Ortwin Adams[SUP] 2 [/SUP], Jan-Steffen Kruessel[SUP] 1 [/SUP], Alexandra Petra Bielfeld[SUP] 1 [/SUP]



Affiliations
Abstract

Objective: To investigate the presence of viral RNA in human semen of patients with severe acute-respiratory syndrome coronavirus 2 (SARS-CoV-2) and to evaluate its presence and relevance in semen parameters.
Design: Pilot cohort study.
Setting: University hospital.
Patient(s): Thirty-four men were distributed as: 1) patients in convalescence (patients with confirmed SARS-CoV-2 infection in pharyngeal swab according to reverse-transcription polymerase chain reaction [RT-PCR] or antibodies); 2) negative control group (no antibodies); and 3) patients with an acute infection (detection of SARS-CoV-2 in pharyngeal swab).
Intervention: Semen and a blood sample were collected from each individual.
Main outcome measure(s): Analysis of semen quality according to the World Health Organization standards. Detection of SARS-CoV-2 by RT-PCR in the native semen sample and after density gradient preparation. Confirmation of immunoglobulin (Ig) A und IgG antibodies in the blood.
Result(s): Eighteen semen samples from recovered men were obtained 8-54 days after absence of symptoms, 14 from control subjects, and 2 from patients with an active COVID-19 infection. No RNA was detected by means of RT-PCR in the semen, including semen samples from two patients with an acute COVID-19 infection. Subjects with a moderate infection showed an impairment of sperm quality.
Conclusion(s): A mild COVID-19 infection is not likely to affect testis and epididymis function, whereas semen parameters did seem impaired after a moderate infection. SARS-CoV-2 RNA could not be detected in semen of recovered and acute COVID-19-positive men. This suggests no viral transmission during sexual contact and assisted reproductive techniques, although further data need to be obtained.

Keywords: ART; COVID-19; SARS-CoV-2; infertility; semen.
 
Back
Top Bottom